This is an outdated version published on 2022-07-17. Read the most recent version.

Pharmacological chaperone therapy for the treatment of inborn errors of metabolism

Authors

  • Patryk Lipiński Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, Warsaw
  • Aleksandra Jezela-Stanek Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw
  • Anna Tylki-Szymańska 1Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, Warsaw

DOI:

https://doi.org/10.18388/pb.2021_451

Abstract

The article describes the mechanism of molecular and pharmacological chaperones in the treatment of inborn errors of metabolism. The literature review of the usage of ambroxol acting as a pharmacological chaperone for beta-glucocerebrosidase in Gaucher disease and Parkinson’s disease associated with GBA variants has been reviewed.

Downloads

Download data is not yet available.
Streszczenie graficzne

Published

2022-07-17

Versions

Issue

Section

Articles